Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iloprost (Ventavis) in patients with Eisenmenger syndrome
2014-000091-25Phase 4Terminated
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Jul 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of iloprost in Eisenmenger syndrome and Plexogenic Pulmonary Arteriopathy (2 arms), sponsored by Royal Brompton and Harefield hospitals. Primary endpoint: 6-minute walk test distance. Started Jul 2014; status: terminated.
02
Drugs
iloprost
03
Conditions
Eisenmenger syndromePlexogenic Pulmonary Arteriopathy
Beyond the preview
Go deeper on 2014-000091-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000091-25.